Northvane

How it works

Spectra Optia: what is this apheresis machine, and does it mean a clinic is safe?

The Spectra Optia separates blood so plasma can be removed and holds a 2007 FDA 510(k) clearance as a therapeutic blood separator. That clearance covers the device only. It names no diseases and does not show that longevity or detox uses work or that a clinic's team and protocol are sound.

Nov 17, 2026Updated Nov 18, 20267 min read

Laboratory centrifuge with rows of sealed sample tubes on a clean bench, representing equipment used to separate blood into its components
Illustration created with AI for this article. It does not show a real clinic or patient.

The Spectra Optia is an apheresis machine: it separates blood into its components so plasma can be removed. It holds a US FDA 510(k) clearance decided in 2007, so a clinic using it has recognized hospital equipment. The clearance does not show that a clinic's advertised use, such as longevity or detox, works, or that its team and protocol are sound.

What is the Spectra Optia, and what does an apheresis machine do?

The Spectra Optia is an apheresis system: equipment that draws blood, separates it, removes one part and returns the rest. In therapeutic plasma exchange (TPE), the machine separates blood "into red cells, white cells, platelets and plasma," and the plasma is discarded and replaced with a substitute fluid.

Plasma is the liquid part of blood, carrying antibodies and other circulating substances. In the rheumatic conditions the American College of Rheumatology (ACR) covers, the removed plasma "contains harmful antibodies," which is why taking it out can help.

The ACR says plasma exchange is typically performed in a hospital or infusion center, with a line in a large vein connected to "a specialized machine operated by a trained nurse." The Spectra Optia is one such machine and appears in published research, including a 2026 study of 114 patients who underwent TPE on the Spectra Optia Apheresis System. For the procedure itself, see how therapeutic plasma exchange works.

Is the Spectra Optia FDA-approved, and how does it compare with the Amicus?

The Spectra Optia is FDA-cleared, not FDA-approved for any use a clinic advertises. Its 510(k) record shows a decision of "Substantially Equivalent (SESE)" under the classification "Separator, Automated, Blood Cell And Plasma, Therapeutic," and that clearance applies to the device.

The record names a device, an applicant, a classification and a decision. Its review panel is listed as Gastroenterology/Urology. It names no diseases and says nothing about aging, longevity or detoxification.

The Amicus, a competing machine, has a record with the same structure and the same FDA product code, LKN:

Company names on a machine or brochure today may differ from the applicant on a filing made years earlier. For a patient, the differences that matter usually lie in the team, the setting and the protocol, not the brand on the cabinet.

How does plasma exchange equipment differ from double filtration and INUSpheresis?

TPE removes your plasma and replaces it with a substitute fluid. Double filtration plasmapheresis (DFPP) instead filters the separated plasma and returns it, setting aside the material the filters catch.

Researchers describe that set-aside material as "eluate plasma from double filtration plasmapheresis procedures" or "sequestered plasma." Plasmapheresis is a broader term for procedures that separate plasma, and clinics do not always use it precisely.

Approach What happens to your plasma Where it stands
Therapeutic plasma exchange (TPE) Removed and discarded, replaced with substitute fluid Graded disease by disease by the American Society for Apheresis
Double filtration plasmapheresis (DFPP) Filtered and returned; filtered material set aside Wellness uses rest on preliminary studies
Young-donor plasma infusion Nothing removed; donor plasma is added FDA says plasma is not FDA-approved to treat normal aging

None of these is plasma donation, dialysis, platelet-rich plasma (PRP) or ozone therapy. If you are weighing a TPE clinic against an INUSpheresis centre, ask the centre which method it uses and what is removed, and see INUSpheresis vs plasma exchange, compared.

Does an FDA-cleared machine mean the treatment works for longevity or detox?

No. Whether a treatment helps depends on clinical evidence for that specific use: established for certain diseases, early for some new uses, and absent for longer life or fewer diseases in healthy people.

Use Status What the sources show
Specific diseases Established ASFA's tenth edition has 93 fact sheets and 183 graded and categorized indications
Lipoprotein apheresis (not TPE) in selected heart patients Established Called "highly effective and well-established"
Microplastics, PFAS, epigenetic clocks, Alzheimer's Emerging Small, uncontrolled or company-tied studies; mixed results
Longevity or "detox" Unproven No study shows longer life or fewer diseases
Long COVID Not supported Sham-controlled trial found no benefit

The American Society for Apheresis (ASFA) guideline summarizes the evidence for each disease separately. It is the reference to check when a clinic cites a condition.

What the emerging studies found

The microplastic, PFAS and epigenetic-clock studies measured blood levels or lab estimates, not health outcomes such as longer life or fewer diseases.

What did not work

In long COVID, 50 patients were randomized to six sessions of TPE or a sham procedure, with "no diferences between groups in any of the efficacy parameters evaluated" (the misspelling is in the original). Separately, the FDA warned in 2019 of "no proven clinical benefit of the infusion of plasma from young donors" for aging or memory loss.

What are the risks, and can the machine or tubing matter?

Most TPE side effects are mild, such as feeling cold, nausea, tingling and fatigue; rarer problems include fainting, low calcium, low blood pressure, and infection or bleeding from a central line. The ACR lists:

For the rheumatic conditions it covers, the ACR says TPE is usually done every 2 to 3 days over 5 to 10 sessions; wellness schedules are set by clinics. More detail is in plasma exchange side effects and how serious they are.

The equipment mattered in one documented way. In the Spectra Optia microplastics study, the reduction was "obscured at low starting levels of MP because of leaching of MP back into the circulation from the plastic apheresis tubing set." No published comparison of safety between machine brands is cited here.

What should you ask a clinic about its equipment?

Ask which machine and procedure the clinic uses, who runs it, and what evidence supports your specific goal. The answers tell you more than the brand name.

  1. Which device do you use, and is this TPE (plasma removed and replaced) or double filtration (plasma filtered)?
  2. Is the device cleared in the US, and under what classification? May I see the record?
  3. Who operates the machine, and is a physician on site during the session?
  4. Will you use a central line or arm veins, and what is your infection-prevention routine?
  5. What replacement fluid do you use, and how do you manage calcium and blood pressure?
  6. How will you time my medications around sessions?
  7. Is my goal an ASFA-graded indication? If not, what study supports it, who funded it, and did it measure health outcomes or only blood levels?
  8. What will you measure before and after, and what would count as no benefit?

Bring the answers to a physician who knows your history before you book. Northvane's list of clinics offering plasma exchange shows who offers which procedure; it is not a ranking.

Common questions

What does a session on a Spectra Optia cost?

The machine brand does not set the price. What you pay depends on the clinic, the number of sessions, the replacement fluid and the setting, and wellness clinics price their own series. Compare full-series quotes rather than single sessions, and check what each includes. For dated figures, see what plasma exchange costs at clinics that publish prices.

Do the experts who write apheresis guidelines have ties to device makers?

Some do, and the guideline discloses it. The 2026 ASFA guideline lists authors who consult for or have received grants from Terumo BCT, and one who received a research grant from Asahi Kasei Medical. Disclosed ties are common in medical guidelines and do not by themselves invalidate the grading, but they are worth weighing alongside the evidence for each disease.

Sources11 cited
  1. [1]510(k) Premarket Notification · accessdata.fda.gov
  2. [2]Plasma Exchange (Plasmapheresis) | American College of Rheumatology · rheumatology.org
  3. [3]Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? · doi.org
  4. [4]510(k) Premarket Notification · accessdata.fda.gov
  5. [5]"sequestered plasma." · doi.org
  6. [6]Important Information about Young Donor Plasma Infusions for Profit | FDA · fda.gov
  7. [7]93 fact sheets and 183 graded and categorized indications · doi.org
  8. [8]Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial. · doi.org
  9. [9]Role of Therapeutic Plasma Exchange in Accelerating the Clearance of Perfluoroalkyl and Polyfluoroalkyl Substances. · doi.org
  10. [10]42 individuals randomized to treatment arms or placebo · doi.org
  11. [11]A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study. · doi.org

For information, not medical advice. Suggest a correction · Editorial policy